Mustang Bio to Present at 8th Annual Partnering Forum at Cell & Gene Meeting on the Mesa Oct 01, 2018
Checkpoint Therapeutics Announces Presentation of Updated Data from Phase 1/2 Trial of EGFR Inhibitor CK-101 Sep 25, 2018
Fortress Biotech Announces Publication of Preclinical Data on AAV-ATP7A Gene Therapy Combined with CUTX-101 (Copper Histidinate) for Menkes Disease in Molecular Therapy: Methods & Clinical Development Sep 12, 2018
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101 Sep 06, 2018
Mustang Bio Announces Presentations on CAR T Therapies at 4th Annual CAR-TCR Summit 2018 Sep 04, 2018
Checkpoint Therapeutics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference Aug 30, 2018
Avenue Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights Aug 14, 2018
Mustang Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights Aug 13, 2018